The differentiation of chronic obstructive pulmonary disease from asthma: A review of current diagnostic and treatment recommendations

Open Nursing Journal

Volumn 7, Issue 1, 2013, Pages 29-34

  Spencer, Pamela ^a   Krieger, Bruce ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

Asthma; Bronchodilators; Chronic obstructive pulmonary disease; Inhaled corticosteroids; United states

Indexed keywords

EID: 84876093536     PISSN: 18744346     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874434601307010029     Document Type: Review

References (36)

1. World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet No. 315. November 2011. Available from: http://www.who.int/mediacentre/factsheets/fs315/en. [Accessed 26 March, 2012].
2. World Health Organization. World Health Statistics 2008. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf. [Accessed 26 March, 2012].
3. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 502-506.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. December 2011. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf. [Accessed 26 March, 2012].
5. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-1259.
6. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2010. Available from: http://www.ginasthma.org/pdf/GINA_Report_2010.pdf. [Accessed 26 March, 2012].
7. Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 2009; 10: 1-157.
8. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010; 1-31.
9. Yawn BP. Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med 2009; 11: 20.
10. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
11. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56: 1157-1161.
12. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
13. National Heart Lung and Blood Institute. Education Strategy Development Workshop: Chronic obstructive pulmonary disease. December 2005. Available from: http://www.nhlbi.nih.gov/health/prof/lung/copd/copd_wksp.pdf. [Accessed 26 March, 2012].
14. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med 2005; 172: 280-305.
15. Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008; 134: 1S-41S.
16. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5: 85-95.
17. Beeh KM, Kornmann O, Beier J, Ksoll M, Buhl R. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004; 98: 591-597.
18. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006; 73: 296-305.
19. Tokuda Y, Miyagi S. Physical diagnosis of chronic obstructive pulmonary disease. Intern Med 2007; 46: 1885-1891.
20. Stephens MB, Yew KS. Diagnosis of chronic obstructive pulmonary disease. Am Fam Physician 2008; 78: 87-92.
21. National Heart Lung and Blood Institute. National Asthma Education and Prevention Panel. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Full report 2007. 28 August 2007. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. [Accessed 26 March, 2012].
22. Sharafkhaneh A, Lan C, Goodnight-White S, Hanania N. Early recognition and diagnosis. Fed Pract 2008; 25: 4-5.
23. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
24. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48: 279-285.
25. van der Molen T, Østrem A, Stallberg B, Østergaard MS, Singh RB. International Primary Care Respiratory Group (IPCRG) Guidelines: management of asthma. Prim Care Respir J 2006; 15: 35-47.
26. Au DH, Bryson CL, Chien JW, et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009; 24: 457-463.
27. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009; 374: 695-703.
28. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint CCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131: 4S-42S.
29. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290: 2301-2312.
30. U.S. Food and Drug Administration. FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). 22 February 2010 Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. [Accessed 26 March, 2012].
31. Dahlén SE, Malmström K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002; 165: 9-14.
32. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002; 19: 61-67.
33. Sandström T. Omalizumab in the management of patients with allergic (IgE-mediated) asthma. J Asthma Allergy 2009; 2: 49-62.
34. Genentech Inc. XOLAIR® [omalizumab]. For injection, for subcutaneous use. Full prescribing information. Initial U.S. Approval: 2003. July 2010. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/103976s5102lbl.pdf [Accessed 26 March, 2012].
35. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715-1726.
36. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med 2007; 101: 1462-1469.